Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2000 Dec;122(3):350-7.
doi: 10.1046/j.1365-2249.2000.01385.x.

T cell activation, apoptosis and cytokine dysregulation in the (co)pathogenesis of HIV and pulmonary tuberculosis (TB)

Affiliations

T cell activation, apoptosis and cytokine dysregulation in the (co)pathogenesis of HIV and pulmonary tuberculosis (TB)

T Hertoghe et al. Clin Exp Immunol. 2000 Dec.

Abstract

Immune parameters were compared in four groups of Ugandan subjects: HIV-and HIV+ adult patients with active pulmonary TB (HIV- PTB n = 38; HIV+ PTB n = 28), patients with HIV infection only (n = 26) and PPD+ healthy controls (n = 25). Compared with healthy controls, CD4 and CD8 T cells from patients with HIV and/or PTB expressed more activation markers (HLA-DR, CD38); their CD8 T cells expressed more CD95 (pre-apoptosis) and less CD28 (co-stimulatory receptor). Peripheral blood mononuclear cells (PBMC) of patients with either HIV or PTB were impaired in interferon-gamma (IFN-gamma) production upon antigenic stimulation. PTB (with or without HIV) was characterized by monocytosis, granulocytosis, increased transforming growth factor-beta 1 production and PPD-induced apoptosis. In vivo CD4 T cell depletion, in vitro increased spontaneous CD4 T cell apoptosis and defects in IFN-gamma responses upon mitogenic stimulation were restricted to HIV+ subjects (with or without PTB). Overlapping and distinctive immune alterations, associated with PTB and HIV, might explain mutual unfavourable influences of both diseases.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Differentiation markers on CD4 T cells (a) and on CD8 T cells (b). Whole blood from 23 HIV PPD+ controls (□), 36 HIV pulmonary TB (PTB)+ patients (hatched), 25 HIV+ PTB subjects (cross-hatched) and 25 HIV+ PTB+ patients (▪) was incubated with anti-CD4 FITC, anti-CD8 PerCP and one of the following PE-labelled monoclonals: isotypic control IgG1, anti-HLA-DR, anti-CD28, anti-CD38 or anti-CD95. Using the isotypic control, the threshold of positivity in PE was fixed on channel 325 and the activation marker expression was calculated as a percentage within the gated CD4, respectively, CD8 T cells. Results are given as mean ±s.e.m. within each patient group. The significance of differences between the groups was calculated using Student's t-test for independent samples, with the following levels of significance: *P < 0·05; **P < 0·01; ***P < 0·001.
Fig. 2
Fig. 2
Apoptosis of CD4+ T cells after antigenic and mitogenic stimulation. Three replicate cultures of peripheral blood mononuclear cells were incubated with medium, PPD, Mycobacterium tuberculosis (MTB) and pokeweed mitogen (PWM) from 24 HIV PPD+ controls (□), 30 HIV PTB+ patients (hatched), 14 HIV+ PTB subjects (cross-hatched) and 16 HIV+ PTB+ (▪) patients. Apoptosis was assessed using the TUNEL test in combination with anti-CD4–PE. Results are expressed as percentage of TUNEL (+) CD4 T cells. Indicated in the figure are the statistical significant differences (paired t-test), between the non-stimulated and the stimulated cultures within each subject group.
Fig. 3
Fig. 3
Secretion of cytokines in cultured peripheral blood mononuclear cells (PBMC). PBMC from 23 HIV PPD+ controls (□), 31 HIV PTB+ patients (hatched), 24 HIV+ PTB subjects (cross-hatched) and 21 HIV+ PTB+ (▪) patients, were cultured in vitro. The respective stimuli are indicated on the abscissa. (a) IFN-γ, (b) transforming growth factor-beta 1, (c) tumour necrosis factor-alpha were measured in the supernatants by ELISA and results were expressed in pg/ml. The differences in cytokine secretion between subject groups were calculated and presented as in Fig. 1.

Comment in

Similar articles

Cited by

References

    1. Kaplan G, Freedman VH. The role of cytokines in the immune response to tuberculosis. Res Immunol. 1996;147:565–72. - PubMed
    1. Rich EA. Pulmonary immune response to Mycobacterium tuberculosis and human immunodeficiency virus. Infect Agents Dis. 1996;5:108–18. - PubMed
    1. Vanham G, Toossi Z, Hirsch CS, Wallis RS, Schwander SK, Rich EA, Ellner JJ. Examining a paradox in the pathogenesis of human pulmonary tuberculosis: immune activation and suppression/anergy. Tuber Lung Dis. 1997;78:145–58. - PubMed
    1. Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med. 1993;178:2249–54. - PMC - PubMed
    1. Toossi Z. Cytokine circuits in tuberculosis. Infect Agents Dis. 1996;5:98–107. - PubMed

Publication types

MeSH terms